Growing risk of infection is associated with the rise in number of ophthalmic surgical operations. . Current research study shows that the risk of bacterial infections is rising post refractive and cataract surgeries. Risk associated with surgical complications, such as, keratitis and postoperative endophthalmitis, highlights the need of highly potent new-generation antibiotics drugs to treat and prevent severe ophthalmic infections. Latest rules published by the Medicare National Surgical Infection Prevention Project show the advantages of postoperative and preoperative antibiotic treatment.

Rise in research regarding ophthalmic bacterial resistance to previous generation fluoroquinolones has driven the progress of advanced fourth-generation antibiotics. For effective regulator of ophthalmic infections, topical antibiotic drugs must efficiently cross through the related ocular tissues. Avascular character of the vitreous and the cornea, in specific, confines the uptake of antibiotics into these tissues. For instance, 0.5% moxifloxacin ophthalmic solution attains improved permeation into the cornea and other ophthalmic tissues as compared to other drugs, such as fluoroquinolones. Due to moxifloxacin’s unique molecular structure, it provides improved bioavailability. Moxifloxacin combines with high lipophilicity molecule for penetration of eye cornea to increase aqueous solubility at physiological pH. The in-vitro research proved greater penetrability in Madin-Darby canine kidney cells for moxifloxacin as compared to gatifloxacin, lomefloxacin, levofloxacin, ofloxacin, norfloxacin, or ciprofloxacin.

Several anti-infectives are available in the market, such as, antifungal, antiviral, antibacterial, etc. in different formulations viz. solutions, suspensions, ointments, etc. These drugs are introduced generally by the use of a tube with a nozzle or by dropper (a container attached with dropper nozzle). Another option to deliver medicine into the eyes is parenteral route, which is, suspension or solution formation introduced by the injection at the anatomical regions of the eye (intraocular injections) to the vitreous, posterior and posterior chambers.

The global market of ophthalmic anti-infective is growing due to increased incidence rate of eye diseases, such as, uveitis, conjunctivitis, dry eye, etc. across the world. Also, the large base of patients suffering from eye diseases globally is driving the global market for ophthalmic anti-infective. With the increase of patient pool across the globe, major market players are increasing R&D investments to capture high share in the market. However, patent expiration and lack of awareness about eye disorders/diseases in underdeveloped countries are some of the key restraints for the global ophthalmic anti-infective market. Moreover, absence of health insurance facilities in several developing countries is another factor hindering the global ophthalmic anti-infective market.

The global ophthalmic anti-infective market can be segmented based on type of infection, type of formulation, type of product, distribution channel, and region. Based on type of infection, the ophthalmic anti-infective market can be classified into antibacterial, antiviral, antifungal, anti-parasitic, and others. In terms of type of formulation, the ophthalmic anti-infective market can be categorized into solutions, suspensions, ointments, and others. On the basis of type of product, the market can be segmented into prescription drugs and over-the-counter drugs. Based on distribution channel, the ophthalmic anti-infective market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies.

In terms of region, the global ophthalmic anti-infective market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global ophthalmic anti-infective market due to availability of advanced drug formulations in the region. Awareness among people about diseases is also a major factor boosting the market in the region. The ophthalmic anti-infective market in Asia Pacific is anticipated to expand at a rapid pace due to increase in incidence of eye infection in the region. Lack of awareness about diseases and unavailability of advanced medication and formulations in underdeveloped countries, such as Lebanon, Syria, Cyprus, Turkey, and Iraq are likely to restrain the growth of the ophthalmic anti-infective market in Middle East & Africa.

Top players operating in the global market of ophthalmic anti-infective are Aerie Pharmaceuticals, ALLERGAN, Valeant, Bayer AG, Genentech, Inc., Novartis AG, Pfizer Inc., among others.

This intelligence report by TMR is the outcome of intense study and rigorous assessment of various dynamics shaping the growth of the market. TMR nurtures a close-knit team of analysts, strategists, and industry experts who offer clients tools, methodologies, and frameworks to make smarter decisions. Our objective, insights, and actionable analytics provide CXOs and executives to advance their mission-critical priorities with confidence.

The scrutiny of the various forces impacting the dynamics of the market, and key and associated industries, guides enterprises in understanding various consumer propositions. Our clients leverage these insights and perspectives to enhance customer experience in the fast-paced business environment.

All our insights and perspectives are broadly based on 4 Pillars or Stages: ASBC-S, which offer an elaborate and customizable framework for the success of an organization. The essence and the roles of these in organizational successes are highlighted below:

  • Agenda for CXOs: TMR, through the study, sets the tone for agendas that are pertinent to CEOs, CFOs, CIOs, and other CXO executives of businesses operating in the market. The perspectives help our clients to bridge the gap between agenda and action plan. TMR strives to offer guidance to CXOs to undertake mission-critical activities empowered by various business analysis tools, and boost the performance of the organizations. The perspectives guide you to decide on your own marketing mix that align well with the policies, visions, and mission.
  • Strategic Frameworks: The study offers how organizations are setting both short-term and long-term strategic plans. Our team of experts collaborate and communicate with you to understand these to make your organizations sustainable and resilient during tough times. The insights help them decide sustainable competitive advantage for each business units.
  • Benchmarking for Deciding Target Markets and Brand Positioning: The assessments in the study provides a scrutiny of marketing channels and marketing mix. Our various teams work synergistically with you to help identify your actual and potential direct, indirect, and budget competition areas. Additionally, the study helps you decide most effective budgets for various processes and promotional activities. Furthermore, the study guides you to set benchmarks for integrating people and processes with the 4Ps of marketing. Eventually, this will empower you to find out unique propositioning strategies and niches.
  • Business Composability for Sustainability (C-S): Constant strategy planning for sustainability characterizing our C-S framework in the report has become more relevant than before in the face of disruptions caused by pandemics, recessions, boom and bust cycles, and changing geopolitical scenario. The TMR study offers a high level of customization to help you achieve business composability. Composable enterprises are increasingly gaining the attention of CXOs in order to help them combat market volatility. Our analysts and industry experts help you wade through such uncertainties and guide you to become a smart sustainable business in entirety.

The study presents scrutiny of region-specific consumer and technology trends, including the most recent industry dynamics. These broadly cover but not limited to

  • North America, South America, and the Americas
  • Asia Pacific and Japan
  • Europe
  • Latin America
  • Middle East and Africa

The study offers data-driven insights and guidance of several aspects. Some of the more notable questions are:

  • What are the major recent trends that can influence the product life cycle and the RoI?
  • Which regulatory trends shape corporate-level, business-level, and functional-level strategies?
  • Which micromarketing initiatives of leading players will bring in investments?
  • What can be the best framework and tools for PESTLE analysis?
  • Which regions will witness rise in new opportunities?
  • Which are the game-changing technologies being used to capture new revenue streams in the near future?
  • Which operational and tactical frameworks are being adopted by various players in gaining customer loyalty?
  • What is the current and expected intensity of competition the market in the near future?

Disclaimer: This market research study is an ongoing effort and extreme care has been taken to maintain the highest levels of accuracy at all stages. However, in the light of the rapidly evolving business dynamics, some region-specific or other segment-specific changes may take time to be part of the study.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Ophthalmic Anti-infective Market